- Accumulating signs of cyclical softness in the US may help Biden’s massive stimulus through Congress, but some compromise will be needed. Powell has nipped in the bud suggestions of an early taper, but we think US long-term interest rates can still rise further. Europe meanwhile is enjoying “positive contagion” from the US: inflation expectations are up, but nominal yields barely moved, and equity is performing well.
Some very tentative signs of progress are emerging on the pandemic front in the Western countries. Lockdowns still work. However, the timing of the re-opening of the economy still depends on the relative speed of the virus propagation and of the vaccination programme. The UK perfectly exemplifies this. While inoculations are happening faster there than in any comparable country, a significant acceleration is still needed to reach the target of covering the most vulnerable segments of the population by mid-February, which the prevalence of a more contagious variant is making even more urgent. In continental Europe, the vaccination programme has not yet really taken off. We maintain our baseline that full normalization should not be expected before this summer.
Some Euro area countries such as Germany and Spain may have (just) avoided another contraction in GDP in Q4, but Q1 looks grim given the intensification in mobility restrictions. In the US, indications of labour market softness are accumulating, with a significant dampening impact on private consumption. This may help Joe Biden get his fiscal package through congress with some bi-partisan support, but we think the massive USD 1.9trn top up to the 0.9trn already agreed is an opening gambit by the incoming administration: necessary compromises will probably shrink the package. Yet, we still think a stimulus of c.10% of GDP this year is likely.
Jay Powell sought to nip in the bud speculations over a quicker than expected taper which would be justified by the stronger fiscal stimulus, but we reiterate our view: merely reassuring on the continuation of the current stance will not suffice to stop the rise in US long-term interest rates. However, Europe seems to benefit from “positive contagion” from the US. Inflation expectations have rebounded in Europe as well, but nominal yields have barely moved. The European equity market outperformed the US. ECB’s Schnabel “pre-emptively dovish” interview last week may have helped. We expect similar comments from Christine Lagarde this week after the Governing Council meeting.
The ECB is probably monitoring very closely Italian politics. A “de facto” confidence vote in the government will take place on Tuesday in the Senate. Early elections remain unlikely at this stage, which probably explains the market’s restrained reaction. The election of Armin Laschet as leader of the CDU, suggesting continuity with Angela Merkel’s European stance, may help keep the peace on the Euro area’s bond market.
This document is for informational purposes only and does not constitute investment research or financial analysis relating to transactions in financial instruments as per MIF Directive (2014/65/EU), nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities.
It has been established on the basis of data, projections, forecasts, anticipations and hypothesis which are subjective. Its analysis and conclusions are the expression of an opinion, based on available data at a specific date. All information in this document is established on data made public by official providers of economic and market statistics. AXA Investment Managers disclaims any and all liability relating to a decision based on or for reliance on this document. All exhibits included in this document, unless stated otherwise, are as of the publication date of this document. Furthermore, due to the subjective nature of these opinions and analysis, these data, projections, forecasts, anticipations, hypothesis, etc. are not necessary used or followed by AXA IM’s portfolio management teams or its affiliates, who may act based on their own opinions. Any reproduction of this information, in whole or in part is, unless otherwise authorised by AXA IM, prohibited.
This document has been edited by AXA INVESTMENT MANAGERS SA, a company incorporated under the laws of France, having its registered office located at Tour Majunga, 6 place de la Pyramide, 92800 Puteaux, registered with the Nanterre Trade and Companies Register under number 393 051 826. In other jurisdictions, this document is issued by AXA Investment Managers SA’s affiliates in those countries.
In the UK, this document is intended exclusively for professional investors, as defined in Annex II to the Markets in Financial Instruments Directive 2014/65/EU (“MiFID”). Circulation must be restricted accordingly.
© AXA Investment Managers 2021. All rights reserved